生物活性

• 描述Voxilaprevir is used for the treatment of Hepatitis C virus infection.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT03164902	Hepatitis C, Chronic ... more >> Nonadherence, Patient Collapse <<	Not Applicable	Active, not recruiting	April 30, 2019	United States, Alabama ... more >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California Zuckerberg San Francisco General Hospital San Francisco, California, United States, 94110 United States, Colorado Peak Gastroenterology Associates Colorado Springs, Colorado, United States, 80907 Denver Health Denver, Colorado, United States, 80204 United States, District of Columbia Providence Health System Washington, District of Columbia, United States, 20017 United States, Florida Orlando Immunology Center Orlando, Florida, United States, 32803 Apex Clinical Research Tampa, Florida, United States, 33612 United States, Illinois The Ruth M. Rothstein CORE Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Massachusetts The Research Institute Springfield, Massachusetts, United States, 01105 United States, Michigan Harper University Hospital Detroit, Michigan, United States, 48201 Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New Mexico Southwest Care Center Santa Fe, New Mexico, United States, 87502 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Washington Harborview Medical Center Seattle, Washington, United States, 98104 United States, Wisconsin SSM Health Dean Medical Group Madison, Wisconsin, United States, 53713 Collapse <<
  NCT02510300	-	-	Enrolling by invitation	September 2027	-
  NCT02202980	Chronic Hepatitis C	Phase 2	Completed	-	New Zealand ... more >> Auckland, New Zealand Christchurch, New Zealand Collapse <<

• 更多
• 参考文献

• [1] Younossi ZM, Stepanova M, et al. Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir. Clin Gastroenterol Hepatol. 2017 Nov 16. pii: S1542-3565(17)31360-5.

  [2] Lawitz E, Poordad F, et al. Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in DAA-experienced patients with genotype 1 HCV. Hepatology.